SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Shasun receives USFDA approval For Abacavir Tablets

01 Nov 2016 Evaluate

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Abacavir Tablets USP, 300 mg. The US market for Abacavir is approximately $30 million according to IMS data. Abacavir Tablets is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents.

The product will be manufactured at the company’s USFDA approved facility at Bangalore and marketed by Strides in the US Market. The product will be launched immediately.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.



Strides Pharma Scien Share Price

1081.80 7.95 (0.74%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: